Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters
February 04, 2016 16:10 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock
January 22, 2016 09:16 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics to Present at Noble Financial Capital Markets’ Twelfth Annual Equity Conference
January 15, 2016 16:31 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Jan. 15, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Receives Approximately $6 Million in Non-Dilutive Funding From New Jersey’s Technology Business Tax Certificate Transfer Program
December 01, 2015 07:45 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Dec. 01, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a specialty pharmaceutical company focused on the development and commercialization of new prescription...
Agile Therapeutics Reports Third Quarter Financial Results
November 09, 2015 16:10 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
The Population Council and WomanCare Global Announce Worldwide License Agreement to Advance Women's Access to Innovative Contraceptive Ring
November 04, 2015 09:15 ET
|
WomanCare Global
NEW YORK and SAN DIEGO, Nov. 4, 2015 (GLOBE NEWSWIRE) -- In a major step forward for women's health, the Population Council and WomanCare Global (WCG) today announced an exclusive worldwide licensing...
Agile Therapeutics Announces Completion of Patient Enrollment in Twirla(R) Phase 3 SECURE Clinical Trial
October 19, 2015 16:08 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics to Participate at FBR Second Annual Healthcare Conference
September 03, 2015 07:45 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Announces Completion of Patient Recruitment in Twirla(R) Phase 3 SECURE Clinical Trial
August 31, 2015 16:05 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Aug. 31, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new...
EWTN Denied Protection Against Contraception Mandate
June 17, 2014 20:15 ET
|
EWTN Global Catholic Network
Irondale, AL, June 17, 2014 (GLOBE NEWSWIRE) -- U.S. District Court Judge Callie V.S. Granade of Mobile, Ala.
issued an opinion on June 17 denying EWTN Global Catholic Network
protection from the...